Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aspirin 325 mg and codeine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and codeine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and codeine 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Codeine (substance) |
Inferred relationship |
Some |
|
Codeine phosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Codeine (substance) |
Inferred relationship |
Some |
|
Product containing caffeine and codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing caffeine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Codeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine- and ibuprofen-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Aspirin- and carisoprodol- and codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Aspirin 325 mg and codeine 60 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing aspirin and carisoprodol and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing aspirin and butalbital and caffeine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Aspirin- and butalbital- and caffeine- and codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Aspirin 300 mg and codeine 8 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and codeine 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing butalbital and caffeine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Aspirin- and codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only aspirin and carisoprodol and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing only aspirin and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing only caffeine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Chlorphenamine and codeine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing only aspirin and butalbital and caffeine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Butalbital and caffeine and codeine and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only bromazine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Codeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine and guaiacol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Product containing only codeine and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine and guaifenesin and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Codeine and ibuprofen only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine and kaolin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine and terpin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine and phenylephrine and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing only codeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Product containing only caffeine and codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Product containing only aspirin and butalbital and caffeine and codeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Aspirin and carisoprodol and codeine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Aspirin and codeine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine and ibuprofen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Allergy to codeine |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Codeine (substance) |
Inferred relationship |
Some |
|
Brompheniramine and codeine and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Brompheniramine- and codeine- and phenylpropanolamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing only bromazine and codeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing brompheniramine and codeine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Codeine and kaolin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine- and promethazine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing codeine and phenylephrine and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing bromazine and codeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Codeine and promethazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Product containing codeine and kaolin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine- and promethazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only codeine and phenylephrine and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
Buclizine- and codeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only buclizine and codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Product containing only buclizine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Buclizine- and codeine- and paracetamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
Urine codeine measurement |
Component |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Urine codeine screening |
Component |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Quantitative measurement of mass concentration of codeine in saliva specimen (procedure) |
Component |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
Codeine monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Codeine (substance) |
Inferred relationship |
Some |
|
Codeine anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Codeine (substance) |
Inferred relationship |
Some |
|